Capital Insight Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,443	Closed	-$203K	–	171
2023 Q2	$203K	Sell	2,443 -852	-26%	-$71.3K	0.05%	170
2023 Q1	$251K	Sell	3,295 -855	-21%	-$70.9K	0.06%	151
2022 Q4	$344K	Sell	4,150 -2,065	-33%	-$167K	0.09%	127
2022 Q3	$493K	Sell	6,215 -8,513	-58%	-$718K	0.13%	110
2022 Q2	$1.09M	Sell	14,728 -1,620	-10%	-$122K	0.26%	99
2022 Q1	$1.47M	Sell	16,348 -785	-5%	-$72.5K	0.3%	100
2021 Q4	$1.92M	Sell	17,133 -3,052	-15%	-$368K	0.39%	92
2021 Q3	$2.54M	Sell	20,185 -172	-0.8%	-$22.1K	0.55%	66
2021 Q2	$2.76M	Sell	20,357 -383	-2%	-$50.4K	0.62%	62
2021 Q1	$2.81M	Sell	20,740 -767	-4%	-$115K	0.68%	54
2020 Q4	$3.03M	Sell	21,507 -1,140	-5%	-$146K	0.76%	43
2020 Q3	$2.52M	Buy	22,647 +4,031	+22%	+$452K	0.71%	51
2020 Q2	$2.08M	Buy	+18,616	New	+$1.83M	0.66%	53